EQL Pharma
EQL Pharma CEO sells shares to finance capital gains tax from option redemption
Axel Schörling has sold 24,066 shares and holds 389,892 shares in EQL Pharma after the sale. The sale corresponded to 5.8% of Schörling's total holdings.
| Datum | 2026-03-27, kl 16:48 |
| Källa | Cision |